Results 31 to 40 of about 1,217,759 (290)

Factors underlying COVID-19 booster vaccine uptake among fully vaccinated adults in Belgium

open access: yes, 2023
Background To tackle waning protection against severe COVID-19 infection, booster doses of the COVID-19 vaccines were recommended among individuals who received their primary course.
L. Catteau   +7 more
core   +1 more source

Safety and Immunogenicity of Homologous Recombinant Adenovirus Type 5-Vectored COVID-19 Vaccine Booster Dose in Healthy Adults Aged 18–60 Years: a Single-Center, Open-Label Trial

open access: yesInfectious Diseases and Therapy, 2023
Introduction The waning antibody levels several months after prime vaccination and the persistent epidemics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) around the world have generated great interest in the evaluation of a booster dose.
Siyue Jia   +12 more
doaj   +1 more source

Predictors of the Third (Booster) Dose of COVID-19 Vaccine Intention among the Healthcare Workers in Saudi Arabia: An Online Cross-Sectional Survey

open access: yesVaccines, 2022
Objective: The COVID-19 pandemic is still continuing throughout the world, with newer genetic variants regularly appearing from different parts of the world.
Sami Alobaidi, Almoutaz Hashim
doaj   +1 more source

A population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients

open access: yesInternational Journal of Infectious Diseases, 2023
Objectives: We aimed to estimate the rate of myocarditis after the messenger RNA (mRNA) COVID-19 booster vaccination by vaccine type, age, and sex. Methods: We used data from the British Columbia COVID-19 Cohort, a population-based cohort surveillance ...
Zaeema Naveed   +5 more
doaj   +1 more source

On the way to mandate booster vaccine dose of coronavirus disease 2019 for transplant recipients: A narrative review of literature

open access: yesIndian Journal of Transplantation, 2022
Coronavirus disease 2019 (COVID-19) vaccine efficacy, especially against severe disease is known to wane over time. We examined current knowledge of COVID-19 vaccine booster dose in solid organ transplant recipients (SOTR).
Vivek B Kute   +6 more
doaj   +1 more source

Frequency and Nuisance Level of Adverse Events in Individuals Receiving Homologous and Heterologous COVID-19 Booster Vaccine

open access: yesVaccines, 2022
This study aimed to compare the occurrence and nuisance of adverse events following administration of each COVID-19 vaccine dose between two groups: individuals given three doses of mRNA vaccine (homologous group, 3 × mRNA, n = 252) and those given two ...
Piotr Rzymski   +6 more
doaj   +1 more source

Relationship between COVID-19 vaccine hesitancy and willingness to pay for the booster dose of COVID-19 vaccine of oncology patients in Taizhou, China

open access: yesAnnals of Medicine, 2023
Objective This population-based study aimed to determine the hesitancy and willingness to pay (WTP) for the booster dose of a coronavirus disease (COVID-19) vaccine among patients with cancer in Taizhou, China.Patients and methods A self-administered ...
Jia-Xiang An   +4 more
doaj   +1 more source

PHS Booster - Advertisements [PDF]

open access: yes, 1930
Digital reproduction of microfilmed fashion advertisements from 1930-1949 that appeared in The Booster, a publication printed out of Pittsburg High ...
The Booster,
core   +1 more source

Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant

open access: yesVaccines, 2022
By vaccinating SARS-CoV-2 naïve individuals who have already received two doses of COVID-19 vaccines, we aimed to investigate whether a heterologous prime-boost strategy, using vaccines of different platforms as the booster dose, can enhance the immune ...
Ka-Wa Khong   +15 more
doaj   +1 more source

Mechanical Solitaire Thrombectomy with Low-Dose Booster Tirofiban Injection [PDF]

open access: yes, 2016
PurposeMechanical thrombectomy using a Solitaire stent has been associated with a high recanalization rate and favorable clinical outcome in intra-arterial thrombolysis.
Hae Woong Jeong   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy